Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLVR logo

Clever Leaves Holdings Inc (CLVR)CLVR

Upturn stock ratingUpturn stock rating
Clever Leaves Holdings Inc
$2.5
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

05/20/2024: CLVR (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: -61.81%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 19
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 05/20/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: -61.81%
Avg. Invested days: 19
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 05/20/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 5.26M USD
Price to earnings Ratio -
1Y Target Price 24
Dividends yield (FY) -
Basic EPS (TTM) -12.63
Volume (30-day avg) 85408
Beta 1.71
52 Weeks Range 1.38 - 8.40
Updated Date 05/20/2024
Company Size Small-Cap Stock
Market Capitalization 5.26M USD
Price to earnings Ratio -
1Y Target Price 24
Dividends yield (FY) -
Basic EPS (TTM) -12.63
Volume (30-day avg) 85408
Beta 1.71
52 Weeks Range 1.38 - 8.40
Updated Date 05/20/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -102.77%
Operating Margin (TTM) -105.91%

Management Effectiveness

Return on Assets (TTM) -23.39%
Return on Equity (TTM) -61.27%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 520385
Price to Sales(TTM) 0.46
Enterprise Value to Revenue 0.18
Enterprise Value to EBITDA -0.19
Shares Outstanding 1754800
Shares Floating 1633346
Percent Insiders 20.89
Percent Institutions 6.34
Trailing PE -
Forward PE -
Enterprise Value 520385
Price to Sales(TTM) 0.46
Enterprise Value to Revenue 0.18
Enterprise Value to EBITDA -0.19
Shares Outstanding 1754800
Shares Floating 1633346
Percent Insiders 20.89
Percent Institutions 6.34

Analyst Ratings

Rating 3
Target Price 24
Buy -
Strong Buy -
Hold 1
Sell -
Strong Sell -
Rating 3
Target Price 24
Buy -
Strong Buy -
Hold 1
Sell -
Strong Sell -

About Clever Leaves Holdings Inc

Exchange NASDAQ Headquaters -
IPO Launch date 2020-12-18 Co-Founder, CEO & Director Mr. Andres Fajardo
Sector Healthcare Website https://cleverleaves.com
Industry Drug Manufacturers - Specialty & Generic Full time employees 296
Headquaters -
Co-Founder, CEO & Director Mr. Andres Fajardo
Website https://cleverleaves.com
Website https://cleverleaves.com
Full time employees 296

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​